Phase I Clinical and Pharmacology Study of Topotecan Given Daily for 5 Consecutive Days to Patients With Advanced Solid Tumors, With Attempt at Dose Intensification Using Recombinant Granulocyte Colony-Stimulating Factor-Reference-Cited by-同舟云学术

Phase I Clinical and Pharmacology Study of Topotecan Given Daily for 5 Consecutive Days to Patients With Advanced Solid Tumors, With Attempt at Dose Intensification Using Recombinant Granulocyte Colony-Stimulating Factor

Published:1993-09-15 Issue:18 Volume:85 Page:1499-1507
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Saltz L.,Sirott M.,Young C.,Tong W.,Niedzwiecki D.,Tzy-Jyun Y.,Tao Y.,Trochanowski B.,Wright P.,Barbosa K.,Toomasi F.,Kelsen D.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/85/18/1499/7806734/85-18-1499.pdf

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topoisomerase inhibitors;Meyler's Side Effects of Drugs;2016

2. Enhanced Lactone Stability of CZ48 in Blood Correlates to its Lack of Toxicity in Mice;Journal of Pharmacy & Pharmaceutical Sciences;2013-05-08

3. Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study;Journal of Clinical Oncology;2011-11-20

4. Phase I Study of Topotecan and Cisplatin in Patients with Small Cell Lung Cancer;Japanese Journal of Clinical Oncology;2010-10-11

5. Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: a phase II study;Investigational New Drugs;2010-05-13